The PTX treatment decreased the incidence of colon cancer and the rate of occurrence of PCNA-positive intestinal epithelial cells compared to those in control rats, indicating that PTX suppressed colon tumorigenesis and intestinal epithelial cell proliferation. This evidence concerns the gene PCNA and malignant colon neoplasm.